I n March 1996, the US government mandated that all food manufacturers fortify enriched grain products with 140 μg of folic acid per 100 g of food by January 1, 1998 . 1 This intervention was implemented to provide increased fetal exposure to folic acid (a synthetic and more highly bioavailable form of naturally occurring folate) in the first month of gestation, a time critical to neural tube development but before many pregnancies are recognized. The fortification rollout rapidly doubled blood folate levels in women of childbearing age 2 and substantially diminished neural tube defects in newborns. 3, 4 At present, 81 countries require folic acid fortification of grain products (eFigure 1 in the Supplement).
Folate may play other important roles in the development of the fetal central nervous system, given its contributions to DNA synthesis, DNA and histone methylation, and gene expression. The hypothesis that prenatal exposure to folate may also influence postnatal brain development arises in part from epidemiologic studies that linked starvation during early fetal life with both neural tube defects and schizophrenia, 5 and is further supported by studies that linked periconceptional folic acid supplements to lower risk of language delay and autism [6] [7] [8] [9] ; however, 1 study failed to find such an association. 10 A critical unanswered question is whether variation in fetal exposure to folate subsequently influences brain development during the formative years preceding late adolescence and early adulthood, a period associated with heightened risk for psychiatric disorders.
The present study used the US rollout of folic acid fortification of grain products to examine the association between increased fetal exposure to folic acid and subsequent cortical development. Our primary measurement was cortical thickness obtained from magnetic resonance imaging (MRI) scans because it provides a clinically relevant developmental marker. Studies of healthy pediatric samples reveal a steady ageassociated decrease in thickness across most of the cortical mantle, 11 a pattern thought to reflect synaptic pruning 12 and cortical myelination. 13, 14 Whereas the trajectory of thinning is typically linear, 11 departures from this pattern can have functional consequences; delayed onset of thinning has been associated with higher intelligence, 15 but accelerated loss of gray matter has been described in patients with schizophrenia 16 and their unaffected relatives, 17 as well as in school-aged children with autism. 18 Using data from normative clinical brain MRI scans accessed from the Massachusetts General Hospital (MGH), 19 we compared cortical thickness indices within a large cohort of youths born just before, during, or just after the rollout of folic acid fortification and who, therefore, would have received progressively greater exposure to folic acid during gestation. Although little, if any, fortification was in place by September 1996, its rapid deployment ensured that the transition was nearly complete within New England by July 1997. 20 Therefore, comparison groups were predefined based on date of birth, so that no individuals in the pre-rollout group (born prior to July 1, 1996) were exposed to fortification during any part of gestation, every individual in the post-rollout group (born after June 30, 1998) was exposed during the entire pregnancy, and individuals in the rollout group (born between these dates) were intermediately exposed. We then turned to 2 additional large, US-based pediatric MRI repositories, the Philadelphia Neurodevelopmental Cohort (PNC) and the National Institutes of Health MRI Study of Normal Brain Development (NIH), to test the reliability and specificity of fortificationrelated associations with cortical development, and the relevance of fortification-associated MRI changes to psychopathologic characteristics.
Methods

MGH Cohort
Patients with brain MRI scans were identified through purposeful sampling of the MGH medical record (eFigure 2A in the Supplement). The search returned 3311 radiology reports, based on both general inclusion criteria (8.0-18.0 years of age at time of scan, date of birth between January 1993 and December 2001, and MRI scans occurring between January 2005 and March 2015) and a predetermined algorithm to optimize age matching of groups. After excluding MRI scans with abnormalities that were identified in the corresponding radiology reports (eTable 1 in the Supplement), and then subjecting the remaining scans to stringent quality control procedures blinded to birthdate (eFigure 2B in the Supplement), we arrived at 292 usable, clinically normative scans, comprising 97 pre-rollout (nonexposed), 96 rollout (partially exposed), and 99 postrollout (fully exposed) unique individuals ( Table 1 and the eAppendix in the Supplement). Study procedures were approved by Partners Human Research Committee, which granted a waiver of informed consent, since this retrospective study of the medical record involved only deidentified data.
Although rapid implementation of the fortification rollout and use of age-matched comparison groups diminished the risk for temporal confounding, we assessed numerous factors that could potentially influence any between-group differences in cortical thickness. To account for socioeconomic and biological diversity in the sample, we extracted from the
Key Points
Question Is increased fetal exposure to folic acid, implemented through population-wide fortification of grain products, associated with clinically meaningful changes in postnatal brain development?
Findings In a cohort of 292 youths 8 to 18 years of age with normative results of clinical magnetic resonance imaging, delayed age-associated thinning of the cerebral cortex, a pattern suggesting reduced risk for severe mental illness, emerged among individuals who gestated during and after the fortification rollout in the United States (1996) (1997) . Studies of 2 additional independent US cohorts (N = 1078) confirmed the reliability and temporal specificity of fortification-associated delays of cortical thinning and demonstrated an associated reduction in psychosis risk.
Meaning Beyond its known association with the prevention of neural tube defects, increased gestational exposure to folic acid through food fortification may protect against psychosis through altered postnatal cortical development. 
PNC Cohort
The PNC participants have been described elsewhere. 22 In brief, participants included here comprised a subset of 861 individuals, 8.0 to 18.0 years of age, recruited from community health settings in Philadelphia, Pennsylvania. Participants underwent standardized clinical and MRI assessment using a single 3-T magnet. Clinical assessment 23 characterized participants as either typically developing or exhibiting psychiatric symptoms, categorized as psychosis spectrum, attenuated psychosis, or other types of psychopathologic conditions (eAppendix in the Supplement). All included MRI scans passed stringent quality control as previously described. 24 The distribution of birthdates among 8-to 18-year-olds in the PNC sample was such that nonexposed (n = 322), partially exposed (n = 189), and fully exposed (n = 350) individuals were well represented (eFigure 3intheSupplement). Study procedures were approved by the institutional review boards of the Children's Hospital of Philadelphia and the University of Pennsylvania. Adult participants provided written informed consent. Minors provided assent, and their parent or guardian provided written informed consent.
NIH Cohort
The NIH participants have been characterized elsewhere. 25 In brief, healthy youths were recruited across 6 sites nationwide and underwent MRI scans on 1.5-T magnets up to 3 times at various ages. Here, we selected a subsample from this cohort whose MRI scans previously passed stringent image quality control, 11 and we constrained it to our age interval of interest (8.0-18.0 years). We also excluded participants who might have been exposed to folic acid fortification based on their age at first enrollment. The final sample included 217 individual participants and 383 MRI scans. All procedures were approved by the relevant institutional review board at each of the 6 pediatric study centers, where the MRI scans took place, at a clinical coordinating center at Washington University in St Louis, and at a data coordinating center at the Montreal Neurological Institute, McGill University. Written informed consent was obtained from parents and adult participants, and minors provided assent.
Statistical Analysis
Primary analyses used general linear models in FreeSurfer, version 5.0 (Martinos Center for Biomedical Imaging). Main analyses in the MGH cohort contrasted mean cortical thickness and age-associated change in thickness (linear and quadratic models) in the fully exposed vs nonexposed groups. Main analyses in the contemporaneous PNC cohort and comparison NIH cohort assessed for significant quadratic associations of age with cortical thickness across each cohort. Nuisance variables, including age, sex, total brain volume (all cohorts), scanner field strength (MGH), and site (NIH), were entered as covariates of no interest. To ensure coverage of the entire cortex, we did not limit the analysis to a priori anatomical regions of interest. Rather, we used 10 000 Monte Carlo simulations to determine whether identified clusters bounded by a vertexwise threshold of P < .05 were sufficiently large to survive control for multiple comparisons across the entire surface (clusterwise P < .05). For clusters demonstrating significant quadratic associations of age with thickness, the delay in cortical thinning (ie, time until thinning onset) was estimated using least squares analyses (MATLAB, version R2015b; Mathworks Inc). To assess the associations of cortical thinning delay with clinical outcomes in the PNC cohort, multinomial logistic regression examined the association of the local age-thickness slope with adjusted odds for diagnosis of psychosis spectrum, attenuated psychosis, and other types of psychopathologic conditions compared with typically developing participants (SPSS, version 25 [SPSS Inc]; eAppendix in the Supplement). 
Results
MGH Cohort
Included and excluded patients were comparable across demographic measures (eTable 2 in the Supplement). Among included individuals, exposure groups did not differ significantly by age at MRI scan, sex, scan indication, or insurance status; a slight but nonsignificant increase in use of psychotropic medications was noted over time, consistent with previous epidemiologic studies. 26 The distribution of scanner field strengths differed among groups owing to a shift from 1.5-to 3-T clinical magnets in the late 2000s, a factor taken into account in the main analy-ses. Tagging patients' last known addresses to block-level data obtained through the 2010 American Community Survey, we observed no differences among fortification groups in per capita use or spending on nonprescription vitamins, or in other measures that could affect folate intake (eg, median income, household educational level, or unemployment rate) ( Table 1 ). Group differences in cortical thickness were observed in bilateral frontal and inferior temporal regions. In each significant cluster, cortical thickness was higher in the fully exposed group compared with the nonexposed group, with intermediate effects observed in the partially exposed group ( Figure 1A show regions for which cortical thickness is greater in the group that was not exposed to fortification, whereas hot colors (red, orange, and yellow) show regions where cortical thickness is greater in the fully exposed group. C, Age-centered regression analyses indicate clusters with significant between-group differences in thickness as a function of age at magnetic resonance imaging (MRI) scan. This analysis indicates that overall group differences largely reflect exposure-related associations within younger individuals. ITG indicates inferior temporal gyrus; L, left, and R, right.
Research Original Investigation
Prenatal Exposure to Folic Acid Fortification and Altered Cerebral Cortex Maturation in Youths strength and manufacturer with cortical thickness, but the direction of these associations varied by region, consistent with prior studies. 27,28 Between-group differences remained significant after adjustment for these variables, and no significant group × field strength or group × manufacturer interactions were observed (eTable 4 in the Supplement).
To understand this pattern in the context of age-associated change in cortical thickness, we next assessed for group differences in intercept (ie, thickness means centered at 8 years of age) and slope (linear age effects), as well as for any differences in nonlinear (quadratic) age-associated change. Intercept in the bilateral frontal cortex (pars orbitalis and precentral) and the right inferior temporal gyrus was higher in the fully exposed group than in the nonexposed group; these differences diminished with age ( Figure 1C ; eFigure 5 and eTable 3 in the Supplement; and Video). There were no significant differences in the cortical thickness-age slope that contributed to the increased cortical thickness in the exposed groups. However, in the left inferior temporal cortex, as well as in the left inferior parietal cortex, we observed significant differences in age-squared effects, where cortical thinning in fully exposed participants was delayed compared with cortical thinning in nonexposed participants (Figure 2A and B; and eTable 5 in the Supplement). Additional modeling using least squares regression localized the onset of cortical thinning in fully exposed participants, defined by the optimal break point between flat and sloped lines, to 13.0 years of age (left inferior temporal gyrus) and 13.8 years of age (left inferior parietal lobule; eFigure 6A in the Supplement).
PNC and NIH Cohorts
The MGH data set relied on clinical MRI scans that were acquired through nonuniform clinical protocols, using different magnets, and within a single US city. To verify and generalize the findings from the MGH cohort, we next turned to 2 additional large US cohorts that were studied prospectively in standardized research settings ( Table 2) : 1 cohort with birthdates centered around the folic acid fortification rollout and MRI scans performed with a single 3-T magnet (PNC; eFigure 3intheSupplement), and 1 cohort that included only youths who were born prior to folic acid fortification (NIH).
Because MRI scans in the PNC data set were collected during a relatively brief time, nonexposed participants were significantly older than partially exposed or fully exposed participants. Whereas between-group cortical thickness differences would be strongly confounded by age differences, examination of age-associated thinning contours provided an opportunity to replicate findings from the MGH cohort. Specifically, younger PNC participants (who were exposed to folic acid fortification) should demonstrate delayed cortical thinning, whereas younger NIH participants (who were not exposed to folic acid fortification) should not demonstrate delayed cortical thinning.
Within the PNC cohort, quadratic (delayed) age-related thinning was observed in 4 clusters that overlapped with those identified in the MGH analysis: left frontal, right inferior temporal, left inferior parietal, and right inferior parietal ( Figure 2C and D; and eFigure 7A and B and eTable 6 in the Supplement). Least squares regression localized the onsets of corti-cal thinning to between 13.0 and 14.3 years of age (eFigure 6B in the Supplement). Conversely, bilateral lingual gyrus (which was not implicated in the MGH cohort) exhibited significantly accelerated cortical thinning.
To confirm that quadratic thinning effects emerged largely after folic acid fortification, we turned to the NIH cohort, in which all included participants were born prior to the rollout. Age-related associations with cortical thickness were assessed within the same 6 clusters that showed delayed thinning in the MGH (left inferior temporal gyrus and left inferior parietal lobule) or PNC (right inferior temporal gyrus, left frontal cortex, left inferior parietal lobule, and right inferior parietal lobule) cohorts. Consistent with a previous analysis 11 that included a more extended age range and that was not limited to nonexposed participants, nonlinear cortical thinning in the NIH cohort was sparse, with only 1 cluster demonstrating significant quadratic thinning (left frontal cortex; Figure 2E and F; and eFigure 7C and eTable 7 in the Supplement). Even so, within this cluster, the break point for thinning occurred at a significantly younger age when compared with the PNC break point (χ 2 = 11.87; P < .001; eFigure 6C in the Supplement).
Risk of Psychosis
To gauge the association of altered cortical thinning with clinically relevant phenotypes, we again turned to the PNC cohort, which included a detailed, standardized clinical characterization of all participants. Of the 861 youths included in the MRI analysis, clinical evaluations determined that 248 were typically developing, 199 had a diagnosis of psychosis spectrum, 105 had attenuated psychotic symptoms, and the remaining 309 had various other psychopathologic conditions, as previously described (eAppendix in the Supplement). 23, 24, 29 Foreachofthe4PNCregions that demonstrated postfortification quadratic thinning, best-fit local thinning slopes were calculated for each participant, based on linear change in cortical thickness across an optimized age range (1 year) centered around that participant ( Figure 3A) . These local slopes were then evaluated as factors associated with participant-level diagnosis of psychosis spectrum, attenuated psychosis, or other types of psychopathologic conditions vs typical development using multinomial logistic regression, controlling for nuisance covariates. Across 3 of 4 regions, flatter (ie, less negative) local slopes were associated with significantly reduced adjusted odds of psychosis spectrum diagnosis (odds ratio, 0.37-0.59; P < .001 to P = .02, Figure 3B and C). Local slopes were not associated with risk of other types of psychopathologic conditions in any region. For participants with attenuated psychosis, local slope associations were stronger than for other types of psychopathologic conditions, but nonsignificant.
Finally, to confirm that the associations of fortification exposure with cortical thinning were not themselves confounded by the inclusion of individuals with psychosis spectrum symptoms in the PNC cohort, we repeated the original analysis of quadratic thinning using only typically developing individuals or participants with other types of psychopathologic conditions (n = 541). Significant quadratic ageassociated thinning persisted in all regions after exclusion of individuals with psychosis spectrum symptoms and youths with attenuated psychosis (eTable 8 in the Supplement).
Discussion
Evaluating 3 independent MRI cohorts of 8-to 18-year-old youths, we investigated the association of prenatal exposure to folic acid fortification with subsequent cortical development through adolescence. Within a large clinical cohort (MGH), we observed widespread increases in frontal and temporal cortical thickness between comparable groups of youths who gestated just after, compared with just before, the rollout of folic acid fortification. Youths who gestated during the rollout, and who therefore had partial exposure, demonstrated intermediate increases, consistent with a dose association. Exposure-associated differences were most pronounced in younger individuals, and in 2 regions (left inferior temporal and inferior parietal), we observed a delay in the onset of age-associated cortical thinning. An analogous pattern was evident in the contemporaneous PNC cohort: individu- A, Surface-wide maps of age-squared associations with cortical thickness in fully exposed (n = 99) minus nonexposed (n = 97) Massachusetts General Hospital (MGH) cohort scans reveal increased age-related quadratic thinning among individuals exposed to folic acid fortification during gestation. Nonexposed greater than fully exposed indicates that cool colors show regions for which β values are greater in the group that was not exposed to fortification. More negative β values reflect stronger quadratic thinning. The cool color (ie, shades of blue) reflects the negative age-squared term in the fully exposed group. B, Age-thickness scatterplot of MGH cohort, indicating emergence of quadratic (delayed) left inferior parietal lobule thinning in participants born after fortification was implemented. C, Surface-wide maps of age-squared associations with cortical thickness in the Philadelphia Neurodevelopmental Cohort (PNC) (n = 861) indicate age-related quadratic thinning in frontal, inferior parietal lobule (IPL), and inferior temporal gyrus (ITG) regions, again driven by delayed thinning in fully exposed individuals. D, Age-thickness scatterplot of the PNC cohort demonstrating delayed thinning in left (L) IPL and right (R) ITG. E, Within the L IPL cluster that demonstrated exposure-associated differences in quadratic thinning in the MGH cohort (A and B), analysis of the nonexposed National Institutes of Health Magnetic Resonance Imaging Study of Normal Brain Development (NIH) cohort indicates linear thinning (evident at the earliest time point). F, Similarly, within the L IPL and R ITG clusters that demonstrated quadratic thinning in the PNC cohort (C and D), only linear thinning was seen in the NIH cohort (383 scans). A and B, Images are masked to show only clusters that survive correction for multiple comparisons (P < .05, clusterwise; for PNC cohort L IPL, the displayed cluster was too small to survive correction at P < .05 but is significant at P < .01). Cortical thickness values in scatterplots represent z-transformed residuals after controlling for nuisance covariates.
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Prenatal Exposure to Folic Acid Fortification and Altered Cerebral Cortex Maturation in Youths als who were exposed to folic acid fortification exhibited delays of cortical thinning of similar duration, which occurred in similar frontal, temporal, and parietal regions as those identified in the MGH cohort. Flatter age-related thinning profiles were associated with reduced risk of psychosis spectrum symptoms in this cohort. In contrast, the NIH cohort, comprising only individuals who were not exposed to fortification, exhibited earlier cortical thinning in the same regions. Collectively, these data suggest an association of prenatal exposure to folic acid fortification with increased cortical thickness through early adolescence, accompanied by delayed onset of cortical thinning and reduced risk of psychosis. Adolescence directly precedes the period of greatest risk for psychiatric disorders, some of which are characterized by reductions in cortical thickness present at the onset of illness. 30 Furthermore, some of the most severe child-onset psychiatric disorders, including autism and early-onset schizophrenia, are associated with marked accelerations in loss of gray matter during the age range that we studied. 16, 18 Within the PNC cohort, reductions in gray matter in multiple brain re-gions were associated with psychosis spectrum status in a previous analysis conducted without regard to exposure to folic acid fortification 24 ; however, these regions differed from those demonstrating fortification-associated thinning delays herein. Rather, within these regions, shallower thinning slopes were associated with reduced risk for psychosis spectrum symptoms, suggesting a possible protective effect of fortificationassociated delays in cortical thinning. This association was relatively specific for psychosis because local slopes were not associated with other psychopathologic conditions, and attenuated associations were seen in individuals with milder psychotic spectrum symptoms. The present findings are consistent with recent reports of salutary behavioral outcomes after periconceptional intake of folic acid [6] [7] [8] [9] 31 and with a recent study linking maternal folate deficiency with reduced brain volume in a cohort of young European children. 32
Limitations
Although relatively large imaging cohorts, replication and temporal specificity analyses using independent samples, and 
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Prenatal Exposure to Folic Acid Fortification and Altered Cerebral Cortex Maturation in Youths linkage of imaging and clinical findings represent the strengths of our study, a number of potential limitations warrant consideration. Unrecognized temporal confounders are of particular concern in natural experimental designs. Critically, the rapid deployment of folic acid fortification in the United States allowed us to study a relatively narrow and continuous range of birthdates, which diminished the risk of potential temporal confounders, including group differences in postnatal exposure to folic acid fortification. We also sought to address a number of other potential clinical, demographic, and socioeconomic confounders through extended use of electronic medical records and block-level American Community Survey data, but we saw no substantial differences among exposure groups. Although, on the population level, the rollout of folic acid fortification rapidly doubled blood folate levels without changing folic acid supplement (vitamin) use, 2,33 the lack of individual-level data on maternal folate intake represents an inevitable limitation of this experiment's design. However, exposure groups were comparable on block-level vitamin spending and consumption. Although exposure groups in the MGH cohort were generally well matched, we cannot rule out the potential role of magnetic field strength differences within that cohort. Field strength effects would not be expected to bias results consistently because previous work indicates that the associations of field strength with cortical thickness measurements vary in direction and magnitude across the cortex 27 ; recognizing this heterogeneity, field strength was entered as a covariate in the surface-wide analysis. Furthermore, within regions demonstrating between-group differences, these differences remained significant in sensitivity analyses that controlled for scanner field strength and manufacturer. Perhaps more important, that similar exposure-related associations with cortical thinning were observed in the PNC co-hort, which used a single 3-T magnet, suggests that scanner differences did not substantially influence the MGH cohort results. More broadly, similar findings across 2 cohorts that differed substantially in terms of population sampling strategy (retrospective and clinical vs prospective and community-based), imaging and clinical assessment (medical record-based vs standardized), and geographic location-but that were comparable in terms of exposure, sex, age, race/ethnicity, and urbanicitysuggest reliability of the findings.
The present findings also raise questions about the longlasting effects of variation in the fetal methylome because folate supplies 1-carbon moieties that regulate gene expression. One possibility suggested by the present results is that programming of cortical maturation in youths is sensitive to fetal folate levels, potentially via epigenetic modification of genes that regulate cortical development, 34 repair of de novo mutations, 35 or mitigation of toxic exposures. [36] [37] [38] [39] Although, to our knowledge, these results are the first to link prenatal exposure to folic acid fortification to changes in subsequent cortical development, the specific mechanisms underlying these effects have yet to be elucidated.
Conclusions
In replicated cohorts, fetal exposure to population-wide folic acid fortification was associated with subsequent alterations in cortical development among school-aged youths. In turn, these cortical changes were associated with reduced risk of psychosis. Our findings suggest that protective effects of prenatal folic acid exposure may extend beyond prevention of neural tube defects and span neurodevelopment during childhood and adolescence. 
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eAppendix. Methods
Sources of data.
We studied 3 independent cohorts in the current investigation. The first dataset (MGH) was acquired from the Partners Research Patient Data Registry (RPDR), a central clinical data warehouse containing the electronic health record data for more than 6.5 million patients in the Partners HealthCare Network. Study procedures were approved by the Partners HealthCare Human Research Committee (IRB), which granted a waiver of informed consent for this retrospective study of the medical record. Using the RPDR Query Tool, radiology reports were obtained for patients meeting general inclusion criteria (age 8.0 to 18.0, receiving non-contrast brain MRI scans at MGH between January 2005 and March 2015). A pre-determined algorithm sampled this cohort to generate age-matched groups of patients born before (1/1/93-6/30/96), during (7/1/96-6/30/98), or after (7/1/98-12/31/01) the fortification rollout as described in greater detail below and in eFigure 2a. Power analysis of pilot data from pre-and post-fortification scans (N=45) indicated a minimum detectible difference of 0.10 to 0.13 mm (depending on region) with 80% power at alpha=.05, based on 50 subjects per group.
The second dataset (PNC) involved 8-to 21-year-old youths who were randomly selected from primary care clinics in the Philadelphia area and who received prospective, standardized MRI scans 1 . IRB approval and informed consent have been described elsewhere 1 . As part of this initiative, 1,445 participants underwent standardized MRI scans. All participants were scanned using a single 3T Siemens Trio magnet located in the Hospital of the University of Pennsylvania. Image quality was assessed by rigorous visual inspection, which primarily eliminated scans with artifacts due to head motion 2 . 1,332 subjects passed the visual quality control. We selected a subsample from this group that was constrained to our age group of interest (8.0-18.0, based on age at scan in months), and eliminated scans with major medical problems that could impact brain function 3 . Scans missing total brain volumes were also excluded. The final PNC sample consisted of 861 individuals, scanned from March, 2010 to July, 2012. Birth dates for the PNC group were centered around the rollout of folic acid fortification, which facilitated the replication of thinning profiles from the MGH dataset (see eFigure 3) 1 .
MRI scans from a third cohort (NIH), obtained from the NIH MRI Study of Normal Brain Development 4 , were used to study thinning trajectories in a sample of deidentified youth who gestated prior to the folate rollout. IRB approval and informed consent have been described elsewhere 5 . This project recruited a total of 431 healthy subjects aging between 4.6 and 18 years (at the time of first enrollment) in 6 pediatric study centers in the US between November 2001 and September 2003. Participants underwent MRI scans in 1.5T GE and Siemens scanners. Data collection for follow up scans continued until November 2007. For our study, we selected a subsample from this cohort that was previously identified as passing stringent quality control measures 6 , and further narrowed it to our age interval of interest (8.0 to 18.0). In order to ensure that none of the subjects in our subsample was exposed to folic acid fortification we only included subjects that were 87 months and older at the time of first enrollment. The final sample included 217 individual subjects and 383 scans.
Medical record sampling in the MGH cohort. Using RPDR the MGH electronic medical record was searched using a pre-determined rubric to obtain age-matched groups of youth, born before (1/1/93-6/30/96), during (7/1/96-6/30/98), or after (7/1/98-12/31/01) the fortification rollout, and who as 8.0-to 18.0-year-olds had undergone clinical brain MRI scans at MGH 2005 to 2015 (eFigure 2a,b) . Radiology reports (n=3,311) were returned by RPDR and manually examined for exclusion criteria (patient deceased since scan (n=51); patient born outside US or no address given (n=152); patient diagnosed with prohibitive comorbidity or image quality issues (n=1,997); see eTable 2). Accordingly, 2,200 reports screened out.
MRI quality control and final scan selection in the MGH cohort.
MRI data for the remaining reports (n=1,111) were then visually inspected for image quality by a trained investigator using ChRIS software 7 . Image inspection was conducted blind to group assignment. 796 scans were excluded due to the failure to meet stringent quality control (presence of any visible motion, susceptibility, or other artifact; poor contrast; ghosting; ringing; aliasing; any blurring of gray-white matter demarcation), by the absence of high-resolution T1-weighted structural scans conducted at MGH, or by the presence of more than one scan per patient (in which case only the first scan was used).
The remaining 315 scans were pre-processed using FreeSurfer v5.0, which provides an automated segmentation of cortical gray matter. Each of the pre-processed scans were then subjected to manual editing of the pial and graywhite boundaries 8, 9 by a single technician who was blind to all subject-level information (including exposure group). An additional 23 scans were excluded during editing due to skull-wrap deformities or other non-editable abnormalities. The remaining 292 scans were included in the analysis. These scans were obtained at various imaging sites at MGH using one of the five scanner types: 1.5T GE, 1.5T Siemens Avanto, 1.5T Siemens Aera, 3T Siemens Trio, and 3T Siemens Skyra. Subjects were sorted into pre-rollout (nonexposed, n=97), rollout (partially exposed, n=96) and post-rollout (fully exposed, n=99) groups based on their date of birth (eFigure 2b). This sample size exceeded that which was pre-determined to be sufficiently powered for group cortical thickness analyses, as above.
Geospatial analysis of socioeconomic variables and vitamin intake.
Addresses from all 292 MGH patients were geocoded with the Esri Business Analyst 2015 address locator. All addresses were located to the address level of accuracy. The address locations were then overlaid with the Business Analyst 2010 block group dataset, and corresponding economic, education, and 6-month consumer vitamin use and spending variables were extracted from the block group each address fell into. Block groups are subdivisions of census tracks and provide neighborhoodlevel analysis of approximately 700 residents. Five addresses could not be located within block groups; for these subjects, zip code-level data were used. Vitamin use data is reported as an index value, which may be compared to nationwide average value of 100.
Image processing. All scans in this study were analyzed using FreeSurfer v5.0 (http://surfer.nmr.mgh.harvard.edu/). The automated image processing pipeline of FreeSurfer performs full characterization of the anatomy including the cortex, white matter/gray matter boundaries, folding patterns, cortical and subcortical regions of interest. Specifically, the typical processing of a structural MR image includes removal of non-brain tissue, automated Talairach transformation, segmentation of the subcortical white matter and deep gray matter structures, intensity normalization, tessellation of the gray/white matter boundary, automated topology correction, and surface deformation following intensity gradients to optimally position the gray/white and gray/cerebrospinal fluid (CSF) borders 8, 10 . Once the cortical model is complete, the cerebral cortex is parcellated into units based on the gyral and sulcal structure 11 . This method uses both intensity and continuity information from the volumetric image to produce representations of cortical thickness, calculated as the closest distance from the gray/white boundary to the gray/CSF boundary at each vertex on the tessellated surface 10 . Methods for cortical thickness measurements have been validated against histological analyses 12 and manual measurements 13 . Importantly, FreeSurfer structural image processing has been demonstrated to show high test-retest reliability across scanner manufacturers and across field strengths 14, 15 . In all imaging analyses, individual thickness maps were smoothed with a 22-mm full width half maximum (FWHM) kernel in order to remove noise-related variations in the images.
Cortical thickness analyses in MGH cohort.
To contrast thickness in nonexposed and fully exposed groups, cortical surface clusters were identified based on significant group differences, defined by a cluster extent threshold p<.05 and cluster-wise correction for multiple comparisons across the entire cortical surface using 10,000 Monte Carlo simulations (cluster-wise p<.05). Z-transformed age, age 2 , sex, total brain volume (TBV), and scanner field strength, which have been shown to influence cortical thickness 6, 16 were entered as nuisance covariates. Of note, both scanner field strength and manufacturer have been associated with effects on cortical thickness measurements (albeit in different directions depending on cortical location) 14, 16 . Within the MGH sample, all GE scans were conducted at 1.5T, while Siemens scans were conducted at 1.5 and 3T. Given that scanner field strength and manufacturer were highly collinear, and that field strength has been associated with stronger effects on cortical thickness than manufacturer 14 , we chose (a priori) field strength rather than manufacturer as a covariate. While each of the five scanner platforms used slightly different T1 acquisition sequences, given the uneven distribution of scanners across the sample ( Table 1) , it would have been impractical to include specific scanner platform as a covariate, over and above scanner field strength.
After significant clusters were defined in the group analysis, individual-level thickness values (indicating mean thickness across all vertices within the group-average cluster) were extracted for those clusters in each subject in the nonexposed, partially exposed, and fully exposed groups. These values were used to generate subject-level plots (e.g., Figure 1b, 2b) and to further quantify group differences in terms of percent difference (eTable 3). Additional sensitivity analyses (MANCOVA) examined effects of both scanner field strength and scanner manufacturer on cortical thickness in regions demonstrating significant between-group differences.
To understand exposure-related effects within the context of brain development, additional surface-wide analyses probed group differences in age-related cortical thinning contours (i.e., intercept, slope, and non-linear thinning). First, difference maps for nonexposed versus fully exposed groups were re-centered at all ages from 8.0 to 18.0 by shifting subject ages in 0.1 y increments (raw values, not z-transformed) accordingly and introducing an age x group covariate into the general linear model. At each age (e.g., 8.0), Monte Carlo analysis was repeated to identify significant between-group differences in cortical thickness at that age point (e.g., Figure 1c, Video) . Second, to determine whether and where differences in age-thickness slope contributed to overall group thickness differences, the age x group interaction term was selected as the covariate of interest (i.e., with z-transformed age, group, sex, scanner strength, and TBV as nuisance covariates). Finally, to determine if groups differed in non-linear thinning contours, age 2 x group was entered as the covariate of interest, with nuisance covariates as above.
Cortical thickness analyses in PNC cohort. Surface-wide analysis of non-linear thinning was assessed across the entire PNC sample. The general linear model included age 2 as the covariate of interest, and z-transformed age, sex, and TBV as nuisance covariates. Scanner strength was not entered into the model as all participants were scanned on the same 3T magnet. As above, clusters were defined as significant based on a cluster extent threshold p<.05 and surface-wide correction for multiple comparisons using 10,000 Monte Carlo simulations (cluster-wise p<.05). Subject-level data on cortical thickness within significant clusters were extracted as above.
Cortical thickness analyses in the NIH cohort.
To determine whether non-linear thinning occurred prior to the fortification rollout, clusters identified as having quadratic age-thinning contours in the MGH or PNC cohorts were assessed for non-linear thinning in the NIH cohort. As the NIH sample comprised subjects with between one and three scans, linear mixed models were employed (SPSS v25), using a diagonal covariance structure. Individuallevel thickness values were extracted from each cluster (as above) and were treated as the dependent variable. Subject ID and visit number were entered as repeated measures; sex and scanner site were entered as categorical covariates; and z-transformed TBV, age, and age 2 were entered as continuous covariates. Clusters where age 2 predicted cortical thickness at p<.05 (uncorrected) were considered to show significant quadratic thinning.
Break point analyses for regions demonstrating quadratic thinning. For regions demonstrating quadratic (delayed) age-related thinning in the MGH, PNC, or NIH cohort, we estimated the break point (age in years) where the age-thickness relationship changed from flat to sloped using least squares analysis (e.g., for eFigure 6). Subjectlevel cortical thickness values were extracted from the cluster (as above); sex, TBV, and other cohort-specific nuisance covariates (scanner strength for MGH, site for NIH) were regressed out, and z-transformed residual cortical thickness values were used for subsequent analysis (SPSS v25). Using Matlab R2015b (https://www.mathworks.com), break points were tested serially, starting at age 9.0 and then incrementally increasing by 0.1 year at a time up to 17.0. Break point range was determined as 9.0-17.0 to ensure sufficient data for the computation of goodness-of-fit at both ends. At a given break point, age-related thinning changes were modeled by a "flat-slope" function as follows: (1) the average of all thickness values from age 8.0 up to and including the break point became the y-value for the "flat" part of the thickness vs. age function, and (2) the best fit line of all remaining thickness values occurring after the break point, constrained by having left edge of the new sloped line contiguous with the flat line established in step 1, became the "slope" part of the thickness vs. age function. At each 0.1-year break point interval, we determined and squared the vertical distance between each cortical thickness data point and the "flat-slope" function derived for that interval; the average of these values became the mean of squares for that particular break point, reflecting the goodness-of-fit of that break point model with respect to the actual data from participants aged 8 to 18. We then plotted the average of squares as a function of break point age, generating an inverted-U shaped curve, where the minimum value of the curve identified the break point with optimal fit.
In the case of the NIH cohort cluster showing quadratic thinning (i.e., where the cluster was defined based on quadratic thinning in the MGH or PNC cohorts, and then found to also be quadratic in the NIH cohort), we determined whether the break point defined through the analysis of NIH data differed significantly from the break point defined through the referring data set (MGH or PNC) using chi-square. For example, if the break point for a given cluster occurred at age 10.0 in the PNC data and at 12.0 in the NIH data, chi-squared was conducted using the NIH data, and determined whether the proportion of subjects age 10 and under differed significantly from the proportion of subjects age 12 and under.
Clinical phenotyping of PNC participants. PNC participants received standardized clinical evaluations using a structured computerized screening instrument (GOASSESS) as previously described [17] [18] [19] . Psychiatric history was obtained from a caregiver (participants age 8 to 10) or caregiver and proband (participants age 11 to 18). Psychosis Spectrum youth (PS) were identified based on (1) an age-deviant score of ≥2 SD above age-matched peers on the Prevention through Risk Identification, Management, and Education (PRIME) Screen-Revised (PS-R) 20 , or the presence of ≥1 PRIME item rated 6 or ≥3 items rated at least 5; (2) endorsed definite or possible hallucinations on the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) 21 psychosis screen; or (3) had an agedeviant total negative/disorganized Scale of Prodromal Symptoms (SOPS) 22 score ≥2 SD above age-matched peers. Psychosis Low youth (PL) included subjects who endorsed more subpsychotic (PS-R) or subthreshold negative or disorganized (SOPS) symptoms than their age-matched peers (≥1 SD) but who did not meet full criteria for PS. Typically Developing (TD) youth lacked any significant psychopathology, history of psychotropic medication use, or history of inpatient psychiatric hospitalization. Remaining youth were classified as Other Psychopathology (OP), indicating significant non-psychotic symptoms (mood, anxiety, attention-deficit, disruptive behavior, or eating disorders) and/or psychotropic medication use. Of the 881 included PNC participants, 209 were classified as TD, 216 as PS, 111 as PL, and the remaining 345 as OP. A total of 30 participants in the OP group, 43 in the PS group, and 19 in the PL group had a history of exposure to psychotropic medications. The prevalence of psychosis spectrum symptoms observed in the PNC sample 19 is consistent with previous studies investigating the similar age range. A meta-analysis of population-based studies in children and adolescents showed higher rates of psychotic-like experiences in youth than in adults (range 5-35%), with meta-analytically derived medians of 17% in children (9-12 years old), and 7.5% in adolescents (13-18 years old) 23 .
Derivation of local cortical thinning slopes in PNC participants.
To test the hypothesis that cortical thinning delays related to fortification exposure conferred protection against psychosis risk, we first needed to derive a subject-level index for whether individuals were situated in relatively flat or steep parts of the age-related thinning curve. As such, best-fit local thinning slopes for cortical thickness versus age were calculated for each subject. Subject-level cortical thickness values were extracted from the cluster as above; sex and TBV were regressed out, and z-transformed residual cortical thickness values were used for subsequent analysis (SPSS v25). Before testing the effects of local best-fit slopes on clinical phenotypes, the method for obtaining these slopes was optimized by varying the temporal window size, i.e., the number of months' worth of data on either side of a given subject to include for that subject's local slope measurement. Data on the extreme ends were excluded (e.g., for a temporal window of six months, only subjects between 8.5 and 17.5 were included). In selecting the optimal window size, normality (Kolmogorov-Smirnov test) of local slope distributions was the primary metric of interest, and slope and kurtosis were secondary metrics of interest. For regions identified as showing significant quadratic thinning in the PNC cohorts, empirical tests of these parameters for various window sizes are summarized below. An inclusion window of six months on either side of the subject was found to be optimal, and therefore this window size was used in the computation of local slopes.
Relation of local cortical thinning slopes to clinical phenotypes in PNC participants.
Multinomial logistic regression models (SPSS v25) were used to determine whether local thinning slopes in clusters with significant quadratic (delayed) thinning predicted diagnosis, with one model per region (4 total analyses). PS, PL, and OP were each compared to TD within the same multinomial model. A priori covariates included age and method of diagnosis ascertainment [binary, based on history from caregiver only (age 8-10) versus caregiver plus proband (age 11-18)], as well as sex and TBV, given established relationships between these factors and psychosis risk. Resulting adjusted odds ratios reflect the relationship between subjects' local thinning slopes and odds of diagnosis (PS, PL, or OP eFigure 4. Additional Clusters Demonstrating Exposure-Related Effects on Cortical Thickness in the MGH Cohort Dot plots showing cortical thickness in the right frontal and bilateral inferior temporal gyrus (ITG) as a function of exposure group (Non, nonexposed; Part, partially exposed; Full, fully exposed), suggesting intermediate effects in the partially exposed group. Bars indicate median values and shaded boxes indicate interquartile ranges. Cortical thickness values are z-transformed residuals after controlling for nuisance covariates.
eFigure 6. Estimate of Thinning Delay in MGH and PNC Clusters Showing Quadratic Age-Related Thinning
Estimates for the break point age, representing the age when cortical thinning begins, were developed for each MGH (A) and PNC (B) cluster showing significant quadratic thinning. "Flat-slope" models were derived for potential break points starting at age 9.0 and continuing upward by increments of 0.1 years to 17.0. For example, the function for the break point occurring at age 11.5 would consist of (1) a straight line from age=8.0 to 11.5, comprising the average thickness value for that interval, and (2) a sloped line from age 11.5 to 18.0, based on the best linear fit of all data points across that interval, further constrained so that the new sloped line was contiguous with the flat line from part (1) . Mean of squares were determined for each incremental break point model, representing the goodness-of-fit of that model to the actual thickness data from participants between 8.0 and 18.0 years old. The mean of squares for each break point model were plotted as a function of break point age; the nadir of the resulting curve reflected the break point age that optimally fit the data. Below, the original cortical thickness versus age data are plotted, indicating at what age the optimal break point occurred. Red data points comprise the "flat" part, and blue data points comprise the "slope" part. Accordingly, the data suggest that cortical thinning among fortification-exposed individuals began between ages 13.0 and 14.3, depending on region. (C) Among the six regions showing quadratic thinning in the MGH and PNC cohorts, five showed no evidence of quadratic thinning in the nonexposed NIH cohort. As such, thinning had already begun by age 8 among NIH participants. However, one region, the left frontal cortex cluster derived in the PNC cohort, did exhibit significant quadratic thinning within the NIH cohort -suggesting that for that region, quadratic thinning was present before the onset of fortification. However, break point analysis for the NIH data in this cluster indicated an earlier onset of thinning (age 12.1) than that observed within the same cluster in the PNC data (age 13.0). Chi-square analysis of the NIH data comparing distributions of data before versus after the two break points indicated a significant difference in thinning onset. 13 (A) Surface-wide maps of age-squared effects on cortical thickness in the PNC cohort (N=861) indicate quadratic age-related thinning, driven largely by individuals who were fully exposed to fortification during gestation. Consistent with the MGH cohort, delayed thinning occurred in left frontal, bilateral inferior parietal lobule (IPL, extending to supramarginal gyrus on the right side), and right inferior temporal gyrus (ITG). Unlike the MGH cohort, accelerated thinning was seen in bilateral lingual gyrus. (B) Agethickness scatterplots depicting subject-level data from panel A. (C) Within in all but one of these clusters, only linear thinning was seen in the nonexposed NIH cohort (N=383 scans), the exception being the left frontal cluster (see also eFigure 6). Images in panel A are masked to show only clusters that survive correction for multiple comparisons (p<.05, clusterwise). Cortical thickness values in scatterplots represent z-transformed residuals after controlling for nuisance covariates. 
